This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Healthcare
Insider Roster
- New Leaf Bpo Associates Ii, L.p., 2024-03-11
- New Leaf Bpo Management Ii, L.l.c, 2024-03-11
- New Leaf Biopharma Opportunities Ii, L.p., 2024-03-11
- New Leaf Venture Management Iii, L.l.c., 2024-03-11
- New Leaf Venture Associates Iii, L.p., 2024-03-11
- New Leaf Ventures Iii, L.p., 2024-03-11
- K Vijay Lathi, 2024-03-11
- P Lauren Silvernail, 2024-03-11
- Ronald Hunt, 2024-03-11
- Nathaniel Luke Walker, Chief Medical Officer, 2024-03-11
- Dunseth Scott Myers, 2024-03-11
- Mark Chin, 2024-03-11
- G Jonathan Drachman, 2024-03-11
- R Andrew Robbins, 2024-03-11
- J Frank Lanza, Principal Fin. & Acctng Ofc., 2024-03-11
- Marie Julia Eastland, President and Ceo, 2024-03-11
- S Joseph Bailes, 2024-03-11
- B James Bucher, Chief Legal Officer, 2024-03-11
- Merck & Co., Inc., 2024-03-11
- Merck Sharp & Dohme Llc, 2024-03-11
- L. Joanne Viney, Director, 2023-04-04
- Alan Colowick, Director, 2023-04-04
- Holger Wesche, Chief Scientific Officer, 2022-02-01
- Natalie Sacks, Chief Medical Officer, 2022-02-01
- Georgia Erbez, Chief Financial Officer, 2022-02-01
- L.p. Management (Cayman) Fund Impact Oncology, Large Shareholder, 2021-06-02
- Mpm Oncology Impact Management Gp Llc, Large Shareholder, 2021-06-02
- L.p. Fund Impact Oncology Ubs, Large Shareholder, 2021-06-02
- Mpm Oncology Impact Management Lp, Large Shareholder, 2021-06-02
- Ansbert Gadicke, Large Shareholder, 2021-06-02
- Mpm Bioventures 2014 Gp Llc, Other, 2021-04-16
- Luke Evnin, Other, 2021-04-16
- Mpm Asset Management Llc, Other, 2021-04-16
- Todd Foley, Other, 2021-04-16
- Mpm Bioventures 2014, L.p., Other, 2021-04-16
- Mpm Bioventures 2014 (B), L.p., Other, 2021-04-16
- Mpm Asset Management Investors Bv2014 Llc, Other, 2021-04-16
- Mpm Bioventures 2014 Llc, Other, 2021-04-16
- Phd Gerald Mcmahon, President and Ceo, 2021-01-30
- Patrick Baeuerle, Director, 2020-06-02
- Plc Bioscience Arix, Large Shareholder, 2020-05-29
- Ltd Holdings Bioscience Arix, Large Shareholder, 2020-05-29
Show All Insiders (42) Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
| 1. | | 0 | $0 | | 0% |
| 2. | | 0 | $0 | | 0% |
| 3. | | 0 | $0 | | 0% |
| 4. | | 0 | $0 | | 0% |
| 5. | | 0 | $0 | | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
| | $23.00 | 21,397,205 | $492,135,715.00 | 1,000 | 2024-03-11 | Filing |
| Large Shareholder | $0.00 | 171,500 | $0.00 | 395,783 | 2023-10-25 | Filing |
| Large Shareholder | $0.00 | 1,372,000 | $0.00 | 1,463,386 | 2023-10-25 | Filing |
| Large Shareholder, Director | $0.00 | 171,500 | $0.00 | 395,783 | 2023-10-25 | Filing |
| Large Shareholder, Director | $0.00 | 1,372,000 | $0.00 | 1,463,386 | 2023-10-25 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
| Large Shareholder | $20.50 | 25,118 | $514,919.00 | 6,328,095 | 2021-06-02 | Filing |
| Large Shareholder | $20.44 | 18,491 | $377,956.04 | 6,353,213 | 2021-06-01 | Filing |
| Large Shareholder | $22.60 | 100 | $2,260.00 | 6,371,704 | 2021-05-28 | Filing |
| Large Shareholder | $21.92 | 3,100 | $67,952.00 | 6,371,804 | 2021-05-28 | Filing |
| Large Shareholder | $20.88 | 10,685 | $223,102.80 | 6,374,904 | 2021-05-28 | Filing |
Filing Period:
| No. | Name | Shares | Value | % Port |
| 1. | | 0 | $0 | 0% |
| 2. | | 0 | $0 | 0% |
| 3. | | 0 | $0 | 0% |
| 4. | | 0 | $0 | 0% |
| 5. | | 0 | $0 | 0% |